...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Zenith Private placement??
Reply New Message
Prev Message Back To Forum Threaded View Next Message

,,yes,,I had forgotten about the peer review,,,,it would certainly not hurt if positive!!,,,,the BoM trial, if successful, will add a significant amount of credence to the science at large!jmo

3 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply